BIDMC launches clinical trials evaluating anti-viral drug remdesivir for COVID-19

(Beth Israel Deaconess Medical Center) Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory infection that has sickened more than 300,000 and killed more than 15,000 around the world to date.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news